Figures6 May 2020 00:31
The profits are not just from Covid tests. See figures below from today's RNS.
(1) The PCR tests launching in May 2020 at an estimated price of £8-10 per test. GDR currently have materials to make 6 million tests. Gross profit margin of at least 60%. Taking the lower estimate of £8 x 6 million = £48 million - 60% of that = £29m profit.
(2) In December 2020, GDR will launch POC tests for £20 per test, with similar 60% profit margin.
(3) WHO Prequalification for its HCV-ID Kit. genedrive has distribution agreements in place with Sysmex in Europe, Africa and Asia (excluding India) and Arkray in India.
(4) Antibiotic-Induced Hearing Loss. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive® unit and £35 per test.
This is all excluding any news to come - such as increase in manufacturing capacity, FDA approval etc.